Cargando…

Correlation of Fecal Immunochemical Testing Levels With Pathology Results in a National Colorectal Cancer Screening Program

INTRODUCTION: Fecal immunochemical testing (FIT) positivity is determined by a threshold decided by individual screening programs. Data are limited on correlation between FIT levels and pathology identified at colonoscopy. Our aim was to examine the correlation between FIT levels and pathology ident...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Reilly, Susanne M., MacNally, Sara, O'Donoghue, Diarmuid, Mooney, Therese, Fitzpatrick, Patricia, Mulcahy, Hugh E., Cullen, Garret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806233/ https://www.ncbi.nlm.nih.gov/pubmed/33512944 http://dx.doi.org/10.14309/ctg.0000000000000277

Ejemplares similares

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test
por: Li, Wen, et al.
Publicado: (2018)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria
por: Knapp, Gregory C., et al.
Publicado: (2021)

Fecal Immunochemical Test as a Screening Method for Colorectal Cancer in University College Hospital Ibadan, Nigeria
por: Labaeka, Elizabeth O., et al.
Publicado: (2020)

Metastatic Melanoma presenting 24 years after surgical resection: a case report and review of the literature
por: Slattery, Eoin, et al.
Publicado: (2009)

Leveraging Fecal Microbial Markers to Improve the Diagnostic Accuracy of the Fecal Immunochemical Test for Advanced Colorectal Adenoma
por: Zhang, Yuhan, et al.
Publicado: (2021)

Feasibility of Mass Screening for Colorectal Cancer Using Fecal Immunochemical Test in Iran
por: Kamangar, Farin, et al.
Publicado: (2017)

Impact of temperature and humidity on performance of the fecal immunochemical test for advanced colorectal neoplasia
por: Park, Chan Hyuk, et al.
Publicado: (2019)

Performance of the Fecal Immunochemical Test in Patients With a Family History of Colorectal Cancer
por: Moosavi, Sarvee, et al.
Publicado: (2019)

Effects of antithrombotic drugs on the results of fecal immunochemical test in colorectal neoplasms screening
por: Ibuka, Takashi, et al.
Publicado: (2021)

Positive fecal immunochemical test results are associated with non-colorectal cancer mortality
por: Jung, Yoon Suk, et al.
Publicado: (2022)

The Accuracy of Fecal Immunochemical Test in Colorectal Cancer Screening: A Meta-Analysis
por: Phuangrach, Nittaya, et al.
Publicado: (2022)

Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal Cancer
por: Michielsen, Adriana J., et al.
Publicado: (2011)

Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment
por: Noonan, Sinead A., et al.
Publicado: (2018)

Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening
por: Iovanescu, Dana, et al.
Publicado: (2016)

Clinical impact of the immunochemical fecal occult blood test for colorectal cancer screening in Brazil
por: Teixeira, Cláudio R., et al.
Publicado: (2017)

Selecting a Cut-off for Colorectal Cancer Screening With a Fecal Immunochemical Test
por: Brenner, Hermann, et al.
Publicado: (2017)

Combining the Fecal Immunochemical Test with a Logistic Regression Model for Screening Colorectal Neoplasia
por: Liu, Feiyuan, et al.
Publicado: (2021)

Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
por: Fisher, Deborah A., et al.
Publicado: (2021)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
por: Ren, Yinan, et al.
Publicado: (2022)

Comment on “ Positive fecal immunochemical test results are associated with non-colorectal cancer mortality”
por: Park, Yong Eun
Publicado: (2023)

Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening
por: van Toledo, D.E.F.W.M., et al.
Publicado: (2023)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

Anorectal stenosis after treatment with tumor necrosis factor α antibodies: a case series
por: Slattery, Eoin, et al.
Publicado: (2010)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018)

Which Fecal Immunochemical Test Should I Choose?
por: Daly, Jeanette M., et al.
Publicado: (2017)

Profiling small RNAs in fecal immunochemical tests: is it possible?
por: Birkeland, Einar, et al.
Publicado: (2023)

Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
por: Stegeman, Inge, et al.
Publicado: (2012)

Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
por: Flitcroft, Kathy L, et al.
Publicado: (2012)

Timing and Risk Factors for a Positive Fecal Immunochemical Test in Subsequent Screening for Colorectal Neoplasms
por: Chiang, Tsung-Hsien, et al.
Publicado: (2015)

Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea
por: Kim, Dae Ho, et al.
Publicado: (2018)

Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening
por: Gies, Anton, et al.
Publicado: (2018)

A large proportion of fecal immunochemical test-positive participants in colorectal cancer screening is symptomatic
por: de Klerk, Clasine M, et al.
Publicado: (2017)

Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?
por: Gies, Anton, et al.
Publicado: (2019)

Comparison of colonoscopy after colonic diverticulitis and positive fecal immunochemical tests for the detection of colorectal neoplasia
por: Nakamatsu, Dai, et al.
Publicado: (2021)

Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening?
por: Trivedi, Mehul, et al.
Publicado: (2022)

Reusing a prepaid health plan’s fecal immunochemical tests for microbiome associations with colorectal adenoma
por: Goedert, James J., et al.
Publicado: (2022)

Performance of the fecal immunochemical test for colorectal cancer and advanced neoplasia in individuals under age 50
por: Heer, Emily, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cg0rmj9uji099a75317654p4oj